Palavra-chave: CML

F359V PATIENTS IN BRAZIL PIOGLITAZONE MULTICENTER STUDY LOW EDUCATION LEVEL CHRONIC MYELOID LEUKAEMIA HMGCLL1 PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION NILOTINIB CYTOGENETIC REMISSION NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PEDIATRIC PATIENTS ALLOGENEIC BONE MARROW BCR/ABL BCR-ABL MUTATIONS THIRD-LINE TKI TREATMENT BCR-ABL BONE MARROW TRANSPLANTATION ENACT CHRONIC PHASE SARS-COV-2 BCR/ABL GENE FIRST LINE TERAPHY HOCT1 2022 DASATINIB CARDIOVASCULAR CHILDREN AND ADOLESCENTS STEM CELL TRANSPLANTATION IMATINIB TYROSINE KINASE INHIBITORS PBSC NILOTINIBE SURVIVAL GENERIC IMATINIB CHRONIC MYELOID LEUKEMIA CARDIOVASCULAR EVENTS D-HPLC DASATINIBE CARDIOVASCULAR RISK GENE SEPT5 EDI-PIO TFR TKI BRAZIL DISCONTINUATION TRIAL BCR-ABL1 PREGNANCY COMORBIDITIES WHO